Ameriprise’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-227,635
Closed -$9.64M 3965
2024
Q1
$9.64M Sell
227,635
-79,590
-26% -$3.37M ﹤0.01% 1820
2023
Q4
$12.8M Buy
307,225
+2,916
+1% +$122K ﹤0.01% 1582
2023
Q3
$11.5M Buy
304,309
+74,054
+32% +$2.79M ﹤0.01% 1585
2023
Q2
$8.73M Buy
230,255
+23,292
+11% +$883K ﹤0.01% 1888
2023
Q1
$5.03M Sell
206,963
-72,070
-26% -$1.75M ﹤0.01% 2317
2022
Q4
$8.1M Buy
279,033
+95,893
+52% +$2.78M ﹤0.01% 1920
2022
Q3
$5.49M Buy
183,140
+25,865
+16% +$775K ﹤0.01% 2147
2022
Q2
$5.69M Sell
157,275
-65,568
-29% -$2.37M ﹤0.01% 2183
2022
Q1
$9.64M Buy
222,843
+71,489
+47% +$3.09M ﹤0.01% 1947
2021
Q4
$7.59M Sell
151,354
-36,060
-19% -$1.81M ﹤0.01% 2184
2021
Q3
$11.9M Buy
187,414
+3,568
+2% +$227K ﹤0.01% 1710
2021
Q2
$13.2M Buy
183,846
+99,945
+119% +$7.19M ﹤0.01% 1688
2021
Q1
$6.19M Buy
83,901
+1,736
+2% +$128K ﹤0.01% 2261
2020
Q4
$6.03M Buy
82,165
+68,710
+511% +$5.05M ﹤0.01% 2138
2020
Q3
$738K Buy
13,455
+1,380
+11% +$75.7K ﹤0.01% 3095
2020
Q2
$803K Sell
12,075
-4,882
-29% -$325K ﹤0.01% 3012
2020
Q1
$1.04M Buy
16,957
+1,500
+10% +$91.7K ﹤0.01% 2804
2019
Q4
$1.36M Buy
15,457
+300
+2% +$26.4K ﹤0.01% 2928
2019
Q3
$1.14M Hold
15,157
﹤0.01% 2965
2019
Q2
$1.3M Buy
15,157
+1,950
+15% +$167K ﹤0.01% 2958
2019
Q1
$1.43M Buy
+13,207
New +$1.43M ﹤0.01% 2891
2014
Q4
Sell
-221
Closed -$34K 4512
2014
Q3
$34K Buy
+221
New +$34K ﹤0.01% 4180